SE423967B - Forfarande for framstellning av porosa tabletter - Google Patents

Forfarande for framstellning av porosa tabletter

Info

Publication number
SE423967B
SE423967B SE7613971A SE7613971A SE423967B SE 423967 B SE423967 B SE 423967B SE 7613971 A SE7613971 A SE 7613971A SE 7613971 A SE7613971 A SE 7613971A SE 423967 B SE423967 B SE 423967B
Authority
SE
Sweden
Prior art keywords
porosa
procedure
tablet preparation
tablet
preparation
Prior art date
Application number
SE7613971A
Other languages
English (en)
Other versions
SE7613971L (sv
Inventor
K W Knitsch
A Hagen
E Munz
H Determann
Original Assignee
Boehringer Mannheim Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Mannheim Gmbh filed Critical Boehringer Mannheim Gmbh
Publication of SE7613971L publication Critical patent/SE7613971L/sv
Publication of SE423967B publication Critical patent/SE423967B/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
SE7613971A 1975-12-16 1976-12-13 Forfarande for framstellning av porosa tabletter SE423967B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2556561A DE2556561C2 (de) 1975-12-16 1975-12-16 Verfahren zur Herstellung von porösen Tabletten

Publications (2)

Publication Number Publication Date
SE7613971L SE7613971L (sv) 1977-06-17
SE423967B true SE423967B (sv) 1982-06-21

Family

ID=5964516

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7613971A SE423967B (sv) 1975-12-16 1976-12-13 Forfarande for framstellning av porosa tabletter

Country Status (13)

Country Link
US (1) US4134943A (sv)
JP (2) JPS5276420A (sv)
AT (1) AT348133B (sv)
BE (1) BE849438A (sv)
CH (1) CH609563A5 (sv)
DE (1) DE2556561C2 (sv)
FR (1) FR2335205A2 (sv)
GB (1) GB1502580A (sv)
IE (1) IE44571B1 (sv)
IT (1) IT1124797B (sv)
NL (1) NL7613818A (sv)
SE (1) SE423967B (sv)
SU (1) SU719480A3 (sv)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE45770B1 (en) * 1976-10-06 1982-11-17 Wyeth John & Brother Ltd Pharmaceutical dosage forms
GB1548022A (en) * 1976-10-06 1979-07-04 Wyeth John & Brother Ltd Pharmaceutial dosage forms
CH637014A5 (de) * 1978-09-29 1983-07-15 Sandoz Ag Verfahren zur herstellung von suppositorien.
HU179442B (en) * 1978-10-30 1982-10-28 Chinoin Gyogyszer Es Vegyeszet Process and equipment for preparing tablets
DE2925009A1 (de) * 1979-06-21 1981-01-08 Basf Ag Zubereitung fuer substanzen, verfahren zu deren herstellung und deren verwendung
US4357312A (en) * 1981-07-16 1982-11-02 The Children's Hospital Medical Center Method of making prolonged release body
GB8624628D0 (en) * 1986-10-14 1986-11-19 Scras Soluble/splitable tablets
US5510115A (en) * 1987-11-16 1996-04-23 Baxter Travenol Laboratories, Inc. Method and composition for administration of beneficial agent by controlled dissolution
US5030203A (en) * 1987-11-16 1991-07-09 Baxter International Inc. Ampule for controlled administration of beneficial agent
EP0432232B1 (en) * 1989-05-01 1994-01-05 Alkermes Controlled Therapeutics, Inc. Process for producing small particles of biologically active molecules
DE69211157T2 (de) * 1991-12-20 1996-10-02 Pfizer Poröse geformte abgabevorrichtung und verfahren zur herstellung derselbe
WO1993013758A1 (en) * 1992-01-13 1993-07-22 Pfizer Inc. Preparation of tablets of increased strength
JP3069458B2 (ja) * 1992-01-29 2000-07-24 武田薬品工業株式会社 口腔内崩壊型錠剤およびその製造法
HUT75616A (en) * 1992-03-17 1997-05-28 Pfizer Method for prooucing porous delivery devices
US5593824A (en) * 1994-09-02 1997-01-14 Pharmacia Biotech, Inc. Biological reagent spheres
US5565318A (en) * 1994-09-02 1996-10-15 Pharmacia Biotech, Inc. Room temperature stable reagent semi-spheres
US20040023948A1 (en) * 1997-03-24 2004-02-05 Green Richard David Fast-dispersing dosage form containing 5-HT1 agonists
GB2328154B (en) * 1997-09-03 1999-06-23 Asoka Malinga Ratwatte Hiran A method of tabletting comprising forming a mixture, containing active agent & free-flowing ice particles, into a tablet & removing the ice from the tablet
US20040265377A1 (en) * 1997-10-27 2004-12-30 Harry Seager Solid dispersing vaccine composition for oral delivery
GB9908014D0 (en) 1999-04-08 1999-06-02 Scherer Corp R P Pharmaceutical compositions
CA2311734C (en) 2000-04-12 2011-03-08 Bristol-Myers Squibb Company Flash-melt oral dosage formulation
KR20010107754A (ko) * 2000-05-26 2001-12-07 민경윤 경구투여용 속용정의 제조 방법
GB0028709D0 (en) * 2000-11-24 2001-01-10 S P A Process
US6544552B2 (en) 2001-01-11 2003-04-08 Particle And Coating Technologies, Inc. Method of producing porous tablets with improved dissolution properties
JP2004520389A (ja) * 2001-02-08 2004-07-08 ファルマシア・コーポレーション 性的不全の治療のための早期効果発現薬剤
US6509040B1 (en) 2001-06-22 2003-01-21 R.P. Scherer Corporation Fast dispersing dosage forms essentially free of mammalian gelatin
BR0212807A (pt) * 2001-09-25 2004-10-05 Ranbaxy Lab Ltd Processo para a preparação de formas de dosagem de dissolução rápida
TWI324074B (en) * 2001-10-09 2010-05-01 Bristol Myers Squibb Co Flashmelt oral dosage formulation
TWI227671B (en) * 2002-06-20 2005-02-11 Kansai Koso Co Ltd Method for producing solid bath salt enclosing shaped article, and humidifying and cooling system
US20040001885A1 (en) * 2002-06-27 2004-01-01 Unchalee Kositprapa Rapidly disintegrating antihistamine formulation
EP1545521A2 (en) * 2002-10-04 2005-06-29 Pharmacia Corporation Compositions and methods for treating sexual dysfunction
WO2004041244A2 (en) * 2002-10-30 2004-05-21 Pharmacia Corporation Oral extended release tablets and methods of making and using the same
US7390503B1 (en) 2003-08-22 2008-06-24 Barr Laboratories, Inc. Ondansetron orally disintegrating tablets
ES2531598T3 (es) * 2004-06-30 2015-03-17 Dsm Sinochem Pharmaceuticals Netherlands B.V. Gránulos que comprenden un antibiótico de ß-lactama
GB0516604D0 (en) * 2005-08-12 2005-09-21 Sandoz Ag Rapidly dispersing/disintegrating compositions
US20080260823A1 (en) * 2007-04-20 2008-10-23 Sciele Pharma, Inc. Orally disintegrating tablet comprising glycopyrrolate for treating sialorrhea
JP5269894B2 (ja) * 2007-06-27 2013-08-21 ハンミ ファーム． シーオー．， エルティーディー． 経口投与用速溶性製剤の製造方法及びその製造、並びに包装装置
WO2011086194A1 (en) * 2010-01-18 2011-07-21 Cephalon France Improved oral lysophilisates containing pvp/va
US20120282335A1 (en) 2010-12-02 2012-11-08 Aptalis Pharmatech Inc. Rapidly dispersing granules, orally disintegrating tablets and methods
WO2012121202A1 (ja) * 2011-03-04 2012-09-13 株式会社クレハ 錠剤型の経口投与用組成物及びその製造方法
US8192659B1 (en) 2011-09-12 2012-06-05 On Demand Therapeutics, Inc. Methods of making microtablets for drug delivery
EP2719373B1 (en) 2012-10-12 2017-04-19 Omya International AG Fast disintegrating solid dosage form formulation comprising functionalized calcium carbonate and method of their manufacture
CN106461327B (zh) 2014-06-09 2019-12-13 泰尔茂比司特公司 冻干法
JP7110360B2 (ja) 2017-10-09 2022-08-01 テルモ ビーシーティー バイオテクノロジーズ，エルエルシー 凍結乾燥方法
JP7495426B2 (ja) 2019-03-14 2024-06-04 テルモ ビーシーティー バイオテクノロジーズ，エルエルシー 凍結乾燥容器用充填治具、システム及び使用方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2877159A (en) * 1957-04-26 1959-03-10 Ciba Pharm Prod Inc Method for preparing tablet granulations
US3607753A (en) * 1967-11-16 1971-09-21 Us Army Method of making lithium ferrite powders
US3812224A (en) * 1969-05-05 1974-05-21 Polysar Ltd Process for the production of porous polymeric materials
US3789119A (en) * 1971-06-01 1974-01-29 Parke Davis & Co Stabilized molded sublingual nitroglycerin tablets
DE2246013A1 (de) * 1972-09-20 1974-03-28 Boehringer Mannheim Gmbh Verfahren zur herstellung von poroesen tabletten

Also Published As

Publication number Publication date
FR2335205A2 (fr) 1977-07-15
FR2335205B1 (sv) 1981-05-29
SU719480A3 (ru) 1980-02-29
US4134943A (en) 1979-01-16
IT1124797B (it) 1986-05-14
JPS56120617A (en) 1981-09-22
GB1502580A (en) 1978-03-01
JPS5824410B2 (ja) 1983-05-20
BE849438A (fr) 1977-06-15
NL7613818A (nl) 1977-06-20
JPS5276420A (en) 1977-06-27
CH609563A5 (sv) 1979-03-15
IE44571B1 (en) 1982-01-13
SE7613971L (sv) 1977-06-17
DE2556561A1 (de) 1977-06-30
DE2556561C2 (de) 1983-04-14
ATA927076A (de) 1978-06-15
AT348133B (de) 1979-01-25
IE44571L (en) 1977-06-16

Similar Documents

Publication Publication Date Title
SE423967B (sv) Forfarande for framstellning av porosa tabletter
DK533476A (da) Kapsler
SE433208B (sv) Forfarande for framstellning av fenoletrar
SE7605139L (sv) Forfarande for framstellning av vattenupptagande cellulosaetrar
SE430336B (sv) Forbettrat forfarande for framstellning av amoxicillinfrihydrat
SE433745B (sv) Forfarande for framstellning av tetrahydroisokinolinderivat
SE426595B (sv) Forfarande for framstellning av cellulosaetrar
DK153811C (da) Rodenticidt praeparat
SE7613768L (sv) Forfarande for framstellning av penicillinestrar
FI56113B (fi) Anordning foer lyftning av en saengbunden patient
SE423390B (sv) Foerfarande foer framstaellning av eburnameninderivat
SE423902B (sv) Forfarande for framstellning av purinderivat
SE7608478L (sv) Farmaceutica
SE7606116L (sv) Forfarande for framstellning av 3-fenoxidbensaldehyder
RO69281A (ro) Procedeu pentru prepararea alchilamino-s-triazinelor
SE420093B (sv) Forfarande for framstellning av 5-fenyl-2-furamidoximer
SE7604781L (sv) Forfarande for framstellning av diarylhydroxibutylaminer
SE434156B (sv) Forfarande for framstellning av penicilliner
DK153776A (da) Fremgangsmade til treimpregnering
SE7610637L (sv) Forfarande for framstellning av 2-alkylindaner
SE446726B (sv) Forfarande for framstellning av 16-metoxiprostaglandiner
SE415175B (sv) Forfarande for framstellning av klorcyan
SE7600179L (sv) Forfarande for framstellnig av alfa-hydroxikarbonylforeningar
SE7602257L (sv) Forfarande for sammanbindning av formdelar
SE409718B (sv) Forfarande for framstellning av 6-aminometylerade-3-oxygenerade-kolest-5-ener

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 7613971-6

Effective date: 19901019

Format of ref document f/p: F